Real-time enrollment status for this b-cell lymphoma clinical trial
Current Status
Active, Not Recruiting
Checked: April 17, 2026 at 2:14 AM UTC
| NCT Number | NCT05458297 |
| Recruiting Status | Active, Not Recruiting |
| Condition | B-cell lymphoma |
| Phase | Clinical Trial |
| Target Enrollment | 223 participants |
| Active Locations | 20 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | March 12, 2026 (Mar 12, 2026) |
As of April 17, 2026: Clinical trial NCT05458297 is currently active_not_recruiting participants. This clinical trial study for b-cell lymphoma is not currently accepting new participants at 20 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05458297 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 20 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05458297 was last updated Mar 12, 2026 (March 12, 2026). HelloStudys verifies this status automatically.